A recent systematic review and meta-analysis revealed that moderate to high doses of cannabidiol were associated with liver enzyme elevation and drug-induced liver injury, meeting the criteria of common adverse drug events.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.